fullscreen

eFinder

eFinder

Home › FDA Leadership Instability › Article

FDA shuffles top drug, biologics leaders in latest shakeup

Cnbc · · 303 words · By Angelica Peebles
FDA Leadership Instability Trump Administration Personnel Management
headphones Listen to the eFinder podcast briefing
Generate a natural audio summary of this story
Daily briefing

What to know about FDA Leadership Instability

Food and Drug Administration is shuffling its top drug and biologics regulators, according to a memo seen by CNBC, days after the departure of former commissioner Marty Makary.

Claims checked 14
Techniques found 1
Topics 2

Coverage spectrum

Coverage gap: Low Right coverage
Left20%
Center80%
Right0%

5 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

Food and Drug Administration is shuffling its top drug and biologics regulators, according to a memo seen by CNBC, days after the departure of former commissioner Marty Makary.

Why it matters

Acting director of the FDA's Center for Drug Evaluation and Research Tracy Beth Høeg and acting director of the Center for Biologics Evaluation and Research Katherine Szarama will leave their roles, according to the memo.

Common ground

The two divisions are responsible for regulating prescription drugs, including pills and vaccines.

Perspective signals

The tension in the story is sharpened by Loaded Language: language that can make the dispute feel more urgent, personal, or adversarial than the underlying facts alone.

open_in_new Read the original article: https://www.cnbc.com/2026/05/15/fda-shuffles-top-drug-biologics-leaders-in-lates…

psychologyPropaganda Techniques Detected

eFinder identified 1 propaganda technique in this article. These signals explain how wording, emphasis, or missing context can shape a reader's interpretation.

warning
Loaded Language 70% confidence
Using words with strong emotional connotations to influence an audience.
Found in this article: eFinder flagged this technique because the story's framing or source language may guide readers toward a particular interpretation. Review the claim checks and evidence below to separate what is directly supported from what is implied by wording or emphasis.
Why it matters: Recognizing loaded language helps readers compare the article's framing with the underlying facts and with coverage from other sources.

fact_checkClaims Checked

eFinder analyzed this article and checked 14 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

info Single Source 4
schedule Pending 4
help Insufficient Evidence 3
check_circle Corroborated 2
verified Verified By Reference 1
help
Claim 1: “Karim Mikhail will replace Høeg at CDER”
INSUFFICIENT EVIDENCE
The evidence explicitly states that Michael Davis, the center's deputy director, will become the acting director of CDER, contradicting the claim that Karim Mikhail will replace Høeg.
travel_explore
web search NEUTRAL — Tracy Beth Høeg, who’d been serving as acting director of the FDA’s Center for Drug Evaluation, is leaving immediately, the people said. Michael Davis, currently the center’s deputy director, will bec…
https://www.msn.com/en-us/news/other/fda-revamps-leadership-…
travel_explore
web search NEUTRAL — Before her CDER appointment, Høeg was in the headlines for exactly this reason, as the Center for Biologics Evaluation and Research (CBER) leader, Vinay Prasad, claimed that research she headed had un…
https://www.yahoo.com/news/articles/fda-appoints-tracy-beth-…
travel_explore
web search NEUTRAL — Last week, it was reported that the recently named leader of the Center for Drug Evaluation and Research (CDER), Dr. Richard Pazdur, M.D., plans to retire from the Agency by the end of December. Dr. P…
https://www.venable.com/insights/publications/fda-pulse/cder…
info
Claim 2: “Høeg in a post on X said she was fired”
SINGLE SOURCE
While there is evidence of Tracy Beth Høeg's presence on X and her role, none of the provided snippets contain a post where she explicitly states she was 'fired'.
travel_explore
web search NEUTRAL — Tracy Beth Høeg is an American sports medicine physician and epidemiologist who has served as the acting director of the Center for Drug Evaluation and Research since December 2025.
https://en.wikipedia.org/wiki/Tracy_Beth_Høeg
travel_explore
web search NEUTRAL — Tracy Beth Høeg, MD, PhD (@TracyBethHoeg) on X. Why is my tweet being labeled as "misleading"? I'm discussing the @CDCgov's own slides. Was it because I was expressing uncertainty about vaccine risks …
https://twitter.com/TracyBethHoeg/status/1403374475123453953
travel_explore
web search NEUTRAL — Tracy Beth Høeg at the Centers for Disease Control and Prevention headquarters in Atlanta, Georgia, on 4 December.
https://www.theguardian.com/us-news/2025/dec/31/tracy-beth-h…
schedule
Claim 3: “Davis becomes the fifth person to lead CDER since last January”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
info
Claim 4: “Acting director of the FDA's Center for Drug Evaluation and Research Tracy Beth Høeg and acting director of the Center for Biologics Evaluation and Research Katherine Szarama will leave their roles”
SINGLE SOURCE
While one search result mentions Tracy Beth Høeg is leaving immediately, the evidence provided for Katherine Szarama leaving is not explicitly found in the provided snippets (they only mention her appointment). The claim about Høeg leaving is mentioned in one specific report.
travel_explore
web search NEUTRAL — Tracy is the second most populated city in San Joaquin County, California, United States. The population was 93,000 at the 2020 census and estimated at 100,136 in 2024. Tracy is located inside a geogr…
https://en.wikipedia.org/wiki/Tracy,_California
travel_explore
web search NEUTRAL — May 8, 2026 · Discover city services, programs, news, and events in the City of Tracy, California. Connecting residents, businesses, and visitors with essential resources.
https://www.cityoftracy.org/Home
travel_explore
web search NEUTRAL — Things to Do in Tracy, California: See Tripadvisor's 4,066 traveler reviews and photos of Tracy tourist attractions. Find what to do today, this weekend, or in May. We have reviews of the best places …
https://www.tripadvisor.com/Attractions-g33184-Activities-Tr…
check_circle
Claim 5: “The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators”
CORROBORATED
Multiple sources report leadership changes at the FDA, including the resignation of the commissioner and the replacement of acting directors at CDER and CBER.
travel_explore
web search NEUTRAL — The Food and Drug Administration (FDA) is a federal agency of the United States Department of Health and Human Services (HHS). The FDA is responsible for protecting and promoting public health through…
https://en.m.wikipedia.org/wiki/Food_and_Drug_Administration
travel_explore
web search NEUTRAL — Apr 29, 2026 · The FDA is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by en…
https://www.fda.gov/
travel_explore
web search NEUTRAL — 3 days ago · Marty Makary is resigning as President Donald Trump's Food and Drug Administration chief. The surgeon and health researcher's tenure had drawn complaints from pharmaceutical executives, a…
https://apnews.com/article/fda-trump-makary-kennedy-vaccines…
schedule
Claim 6: “CBER has also seen multiple faces in the job over the past year, including Vinay Prasad, who left the division then returned only to leave again”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 7: “the Trump administration is trying to fill health vacancies, including the director for the Centers for Disease Control and Prevention and the surgeon general”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
help
Claim 8: “the FDA... is responsible for regulating products that account for some 20% of consumer spending in the U.S.”
INSUFFICIENT EVIDENCE
No evidence was found to support or refute the specific statistic that FDA-regulated products account for 20% of consumer spending.
help
Claim 9: “Lowell Zeta will take over as acting chief of staff”
INSUFFICIENT EVIDENCE
No evidence was found for the claim regarding Lowell Zeta.
verified
Claim 10: “The two divisions are responsible for regulating prescription drugs, including pills and vaccines.”
VERIFIED BY REFERENCE
Wikipedia and official FDA pages confirm that CDER regulates prescription and over-the-counter drugs, and CBER regulates biological products (including vaccines).
travel_explore
web search NEUTRAL — Prescription drugs Over-the-counter drugs.The FDA requires a four-phased series of clinical trials for testing drugs. Phase I involves testing new drugs on healthy volunteers in small groups to determ…
https://en.wikipedia.org/wiki/Center_for_Drug_Evaluation_and…
travel_explore
web search NEUTRAL — In this section. Center for Drug Evaluation and Research (CDER).As part of the U.S. Food and Drug Administration (FDA), CDER regulates over-the-counter and prescription drugs, including biological the…
https://www.fda.gov/about-fda/fda-organization/center-drug-e…
travel_explore
web search NEUTRAL — Basics of Interactions with FDA (CDER/CBER).CBER and CDER prefer to provide holistic feedback on development plans that will enable you to move non-clinical, clinical, and manufacturing aspects of the…
https://seed.nih.gov/sites/default/files/2023-12/Overview-of…
info
Claim 11: “Szarama will remain at the agency”
SINGLE SOURCE
The provided evidence for 'Katherine' consists of general name meanings and unrelated YouTube videos; there is no evidence regarding Katherine Szarama's continued employment status after leaving her role.
travel_explore
web search NEUTRAL — Katherine (/ kæθərɪn /), also spelled Catherine and other variations, is a feminine given name. The name and its variants are popular in countries where large Christian populations exist, because of i…
https://en.wikipedia.org/wiki/Katherine
travel_explore
web search NEUTRAL — Katherine Elizabeth plays Minecraft One Block as a fairy! This one single block will turn into a magical floating fairy flower island!
https://www.youtube.com/channel/UCsBBCjvcuWX3fPVSwboM-hw
travel_explore
web search NEUTRAL — Dec 13, 2025 · What Does Katherine Mean? The name Katherine is most typically associated with the Greek word katharos, meaning “pure.” This etymology suggests a sense of innocence, clarity, and moral …
https://momlovesbest.com/katherine-name-meaning
check_circle
Claim 12: “former commissioner Marty Makary [departed]”
CORROBORATED
Three independent sources (AOL, Ars Technica, and another web result) confirm that Marty Makary resigned/departed from his role as FDA commissioner.
travel_explore
web search NEUTRAL — FDA Commissioner Marty Makary resigned his position, stepping aside amid a swirl of reports that his tenure was coming to an end.The FDA commissioner is responsible for overseeing and regulating drugs…
https://www.aol.com/articles/marty-makary-resigns-fda-commis…
travel_explore
web search NEUTRAL — FDA Commissioner Marty Makary to resign.Marty Makary departs FDA after clashes with Trump over fruit-flavored vapes.
https://news.google.com/stories/CAAqNggKIjBDQklTSGpvSmMzUnZj…
travel_explore
web search NEUTRAL — Marty Makary on Tuesday resigned from his role as commissioner of the Food and Drug Administration, days after news broke on Friday that the White House had signed off on plans to fire him.
https://arstechnica.com/health/2026/05/fda-chief-resigns-aft…
info
Claim 13: “Michael Davis will replace Szarama at CBER”
SINGLE SOURCE
The evidence confirms Katherine Szarama was appointed as acting director of CBER, but there is no mention of Michael Davis replacing her there (he is linked to CDER).
travel_explore
web search NEUTRAL — Here’s what caught our attention: 1 FDA Names Acting CBER Director: Katherine Szarama has stepped in as acting director of the FDA’s Center for Biologics Evaluation and Research after Vinay Prasad’s d…
https://www.linkedin.com/posts/kendalleoconnell_before-we-he…
travel_explore
web search NEUTRAL — Katherine Szarama, who has served as Prasad’s deputy at the Center for Biologics Evaluation and Research since December, joins a long list of temporary leaders at the Department of Health and Human Se…
https://www.biospace.com/fda/fda-taps-szarama-as-acting-cber…
travel_explore
web search NEUTRAL — Katherine Szarama named acting director of FDA’s vaccines and biologics center. Szarama was deputy to Vinay Prasad, who just left the agency. Manage alerts for this article.
https://www.statnews.com/2026/04/30/fda-names-katherine-szar…
schedule
Claim 14: “Makary resigned after days of reports that President Donald Trump wanted to oust the commissioner”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.